About AACI

What is AACI?

AACI, the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that aims to further the understanding and treatment of allergic and immunologic disease.

By offering a high-visibility forum for new insights and discussions, the journal provides a platform for the dissemination of allergy and clinical immunology research and reviews amongst allergists, immunologists and other physicians, healthcare workers, medical students and the public world wide. This journal was previously published by BC Decker and for further information about the previous content, please contact the editorial e-mail address at: editorial@aacijournal.com.

The fields of allergy and clinical immunology concern human diseases in which disorders of the immune system play a significant role. It is considered that diseases of the immune system are best understood through a clear grasp of normal immune mechanisms and the ways in which these processes become dysfunctional.

AACI reports on basic research and clinically applied studies in the following areas and other related topics: asthma and occupational lung disease, rhinoconjunctivitis and rhinosinusitis, drug hypersensitivity, allergic skin diseases, urticaria and angioedema, venom hypersensitivity, anaphylaxis and food allergy, immunotherapy, immune modulators and biologics, immune deficiency and autoimmunity, T cell and B cell functions, regulatory T cells, natural killer cells, mast cell and eosinophil functions, complement abnormalities.

Content overview

AACI considers the following types of articles:

• Research: reports of data from original research.
• Reviews: comprehensive, authoritative, descriptions of any subject within the journal’s scope. Reviews are often commissioned from experts in the field, and should have an educational aim. Long reviews and short reviews have different readerships and characteristics - a mixture of both is ideal.
• Case reports: reports of clinical cases that can be educational, describe a diagnostic or therapeutic dilemma, suggest an association, or present an important adverse reaction. All case report articles should indicate that informed consent to publish the information was granted from the patients or their guardians.
• Letter to the Editor: these can take three forms: a substantial re-analysis of a previously published article, or a substantial response to such a re-analysis from the authors of the original publication, or an article that may not cover 'standard research' but that may be relevant to readers.

Peer review policies

The reports of at least two reviewers will be considered when deciding on acceptance or rejection of a manuscript. Final decisions rest with the Editors-in-Chief who aim to provide an initial decision within six weeks. In cases where authors challenge an Editor's negative decision with well founded arguments, the manuscript can be sent to one or two additional reviewers at the discretion of the Handling Editor, and a final decision will be made upon their recommendations. Manuscripts are sent to statisticians at the request of reviewers.

Edited by Richard Warrington, AACI is supported by an expert Editorial Board.

Publishing in AACI

All articles are listed in PubMed immediately upon acceptance (after peer review), and are covered by PubMed Central, CAS and Embase.

Articles in AACI should be cited in the same way as articles in a traditional journal. However, because articles in this journal are not printed, they do not have page numbers. Instead, they have a unique article number.

The following citation:

Allergy Asthma Clin Immunol 2004, 2:1

refers to article 1 from volume 2 of the journal.

As an online journal, AACI does not have issue numbers. Each volume corresponds to a calendar year.

To keep up to date with the latest articles from AACI, why not register to receive alerts? Registration also enables you to customise your subject areas of interest, store your searches, and submit your manuscripts.

Submission of manuscripts

Manuscripts should be submitted electronically to AACI using the online submission system. Full details of how to submit a manuscript are given in the instructions for authors.

General journal policies

AACI is published by BioMed Central, an independent publisher committed to ensuring peer-reviewed biomedical research is open access. That means it is freely and universally accessible online, it is archived in at least one internationally recognised free access repository, and its authors retain copyright, allowing anyone to reproduce or disseminate articles, according to the BioMed Central copyright and licence agreement. AACI however, has taken this further by making all its content open access.

AACI's articles are archived in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and also at INIST in France and in e-Depot, the National Library of the Netherlands' digital archive of all electronic publications. The journal is also participating in the British Library's e-journals pilot project, and plans to deposit copies of all articles with the British Library.

AACI is able to deliver summaries of frequently updated content via Really Simple Syndication (RSS) feeds. These are accessible via the orange "XML" button at the top of the list of recent articles or the list of most accessed articles. For more information about RSS feeds see our publisher's website.

For further information about general policies please see the instructions for authors.